31 July 2018 · Intended audience: This document is intended as a reference and source of information to the following audiences: Nursing staff who handle cytotoxic chemotherapy (Oncology /…
1 June 2017 · This protocol applies to small molecule products of all presentations, manufactured from non-sterile starting materials and sterilised in their final container.
1 June 2017 · To support NHS compounding units and purchasers to derive and assess stability data for pharmaceutical products (Specials and extemporaneously compounded).
23 January 2017 · This YCD applies to small molecule products of all presentations prepared by aseptic manipulation of sterile pharmaceutical products.
16 December 2016 · The purpose of this document is to give guidance to those outsourcing PN compounding on the risks in the outsourcing and supply process and to…
29 February 2016 · This document is intended to cover stability testing of all oral liquid formulations including suspensions, emulsions, solutions and powders for reconstitution
31 July 2015 · Following a series of patient deaths in 2014 linked with Bacillus cereus infections (MHRA, 2014) and observations of practice and microbiological monitoring made during…